Study guide
Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas
ABWM Certified Wound Specialist CWS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Overview
1.1 About the ABWM CWS Exam 1.2 How to Use This Study Guide & Blueprint Strategy
2 Chapter 2: Comprehensive Patient & Wound Assessment
2.1 Patient History & Systemic Risk Factors 2.2 Physical Examination & Anatomical Wound Classification 2.3 Quantitative Wound Measurement & Documentation 2.4 Bioburden & Infection Assessment
3 Chapter 3: Vascular Assessment & Diagnostic Testing
Section 3.1: Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) Interpretation Section 3.2: Advanced Vascular Diagnostics Section 3.3: Neuropathic & Sensory Assessment
4 Chapter 4: Laboratory, Imaging & Diagnostic Approaches
Section 4.1: Laboratory Evaluation in Wound Care Section 4.2: Imaging Modalities for Wounds & Bone Section 4.3: Differential Diagnosis of Recalcitrant & Atypical Wounds
5 Chapter 5: Physiology of Wound Healing & Tissue Repair
5.1 Hemostasis & Inflammatory Phase Dynamics 5.2 Proliferative & Remodeling Phases 5.3 Growth Factors & Extracellular Matrix (ECM)
6 Chapter 6: Biofilm Biology & Wound Bed Preparation
6.1 Biofilm Pathophysiology & Management Strategies 6.2 TIME Framework & Wound Bed Preparation 6.3 Moisture Balance & Exudate Management
7 Chapter 7: Pressure Injuries & Moisture-Associated Skin Damage
7.1 Pressure Injury Pathophysiology & NPIAP Staging 7.2 Risk Assessment Tools & Support Surface Selection 7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
8 Chapter 8: Lower Extremity Ulcers (Venous, Arterial & Mixed)
Section 8.1: Venous Leg Ulcers & CEAP Classification Section 8.2: Arterial Ulcers & Peripheral Artery Disease Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema
9 Chapter 9: Diabetic Foot Ulcers & Neuropathic Wounds
Section 9.1: Diabetic Foot Ulcer Pathophysiology & Classification Section 9.2: Diabetic Foot Infection & Osteomyelitis Management
10 Chapter 10: Thermal Injuries, Surgical Wounds & Special Etiologies
Section 10.1: Burn Injuries & Thermal Damage Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types
11 Chapter 11: Debridement & Topically Applied Therapies
Section 11.1: Debridement Modalities & Selection Section 11.2: Wound Dressing Selection & Categories Section 11.3: Topical Antimicrobial Agents & Antiseptics
12 Chapter 12: Compression Therapy & Advanced Off-Loading
Section 12.1: Compression Therapy Modalities & Science Section 12.2: Off-Loading Devices & Biomechanical Protection
13 Chapter 13: Advanced & Adjunctive Wound Therapies
Section 13.1: Negative Pressure Wound Therapy (NPWT) Section 13.2: HBOT, Biophysical Agents & Advanced Biologics Section 13.3: Systemic Nutrition, Hydration & Pain Management
14 Chapter 14: Professional Practice, Reimbursement & Interprofessional Care
14.1 Professional Ethics, Scope of Practice & ABWM Guidelines 14.2 Documentation, Coding & Reimbursement Standards 14.3 Interprofessional Team Roles & Quality Improvement
Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas
Key Takeaways Explain This Topic AI
Surgical wound healing progresses via primary intention (sutured/stapled closure), secondary intention (granulation and contraction of open wounds), or tertiary intention (delayed primary closure after controlling bioburden and edema).
Abdominal wound dehiscence risk factors include surgical site infection, excessive mechanical strain (coughing, ascites, distension), severe malnutrition (albumin < 3.5 g/dL), obesity, and systemic steroid use.
Copious, salmon-colored serosanguineous drainage from an abdominal incision is the classic pathognomonic sign of impending sub-fascial dehiscence and potential visceral evisceration.
Management of acute evisceration requires placing the patient in low Fowler's position with knees flexed, covering exposed viscera with sterile saline-soaked dressings, keeping the patient NPO, and securing emergent surgical intervention.
Skin grafts require a vascularized recipient bed; flaps bring their own blood supply and are preferred when bone, tendon, or poorly granulating beds are exposed.
Last updated: July 2026
Surgical Wounds, Dehisced Incisions & Fistulas
Surgical wounds represent a major portion of acute and chronic wound care consultations across inpatient surgical units, outpatient wound centers, and long-term care settings. While clean surgical incisions approximated with sutures or staples usually heal uneventfully, complications such as surgical site infections (SSIs), mechanical tension, breakdown (dehiscence), organ exposure (evisceration), and abnormal tract formation (enterocutaneous fistulas) create complex clinical challenges. ABWM CWS candidates must demonstrate expertise in surgical healing mechanisms, risk stratification, emergency evisceration protocols, and enterocutaneous fistula pouching techniques.
1. Intentions of Surgical Wound Healing
Wound healing after surgical intervention occurs through three distinct anatomical pathways, categorized by the timing and method of closure.
Healing Intention Mechanism & Technical Method Indicating Clinical Scenarios Healing Velocity & Scar Formation Bioburden & Complication Risk
Primary Intention (Primary Closure) Surgical approximation of clean wound margins using sutures, staples, dermal clips, or adhesive tissue tape. Clean or clean-contaminated surgical incisions with minimal tissue loss and well-apposed edges. Rapid re-epithelialization within 24–48 hours; minimal granulation tissue; fine linear scar. Low risk of infection or breakdown when aseptic technique is maintained.
Secondary Intention Wound left open to heal spontaneously through granulation tissue formation, wound contraction, and peripheral re-epithelialization. Heavily contaminated wounds, infected surgical sites, dehisced incisions, or extensive tissue loss. Prolonged healing trajectory; extensive extracellular matrix deposition; pronounced scar tissue. High risk of persistent bioburden, delayed contraction, and chronic wound stalling.
Tertiary Intention (Delayed Primary Closure) Wound intentionally left open for 3–5 days for serial debridement and infection control, followed by surgical closure or grafting. Grossly contaminated traumatic wounds, severe abdominal sepsis, or surgical wounds requiring edema reduction before closure. Intermediate healing velocity; moderate scar formation once closed cleanly. Mitigates infection risk by allowing bacterial clearance before final closure.
2. Surgical Wound Dehiscence & Evisceration
Dehiscence is defined as the partial or total separation of previously approximated surgical wound layers (epidermal, dermal, subcutaneous, or fascial). When dehiscence involves all layers of the abdominal wall, allowing abdominal viscera (most commonly small intestine) to protrude outside the abdominal cavity, the condition is termed evisceration .
Dehiscence Risk Factors & Etiologies
Dehiscence occurs when localized mechanical forces exceeding the tensile strength of the healing tissue or suture line coincide with impaired cellular repair. Key predisposing factors include:
Local & Infection Factors: Surgical Site Infection (SSI) is the leading cause of dehiscence. Bacterial pathogens release collagenases and proteases that degrade the newly synthesized fibrin-collagen matrix. Seroma or hematoma accumulation creates fluid pressure that separates tissue planes.
Mechanical Stress Factors: Sudden increases in intra-abdominal pressure from violent coughing, postoperative emesis, severe abdominal distension, ileus, or ascites place intense shearing tension on fascial closure lines.
Systemic & Host Factors:
Severe Malnutrition: Hypoalbuminemia (serum albumin < 3.5 g/dL) and low prealbumin (< 15 mg/dL) impair fibroblast proliferation and collagen synthesis.
Obesity (BMI > 30 kg/m²): Adipose tissue has poor vascularity, predisposing to localized fat necrosis and ischemia. Increased abdominal mass exerts constant outward tension on fascial sutures.
Diabetes Mellitus: Uncontrolled hyperglycemia impairs neutrophil chemotaxis, phagocytosis, and collagen cross-linking.
Immunosuppression & Steroid Use: Systemic corticosteroids inhibit inflammatory mediator release, macrophage recruitment, and fibroblast activation.
Advanced Age & Tobacco Use: Impaired microvascular perfusion and diminished tissue elasticity.
Clinical Presentation: The Warning Sign
The classic pathognomonic indicator of impending deep sub-fascial abdominal dehiscence is copious, salmon-colored (serosanguineous) wound drainage appearing between postoperative days 4 and 14. This fluid represents peritoneal fluid mixed with red blood cells leaking through a disrupted fascial layer beneath intact superficial skin sutures.
Emergency Evisceration Management Protocol
Evisceration is a surgical emergency requiring immediate bedside intervention while preparing the patient for emergency laparotomy:
Call for Immediate Surgical Assistance: Alert the operating room and surgical team.
Position the Patient: Place the patient in low Fowler's position (head of bed elevated 15–30 degrees) with flexed knees and hips . This position minimizes intra-abdominal pressure and reduces tension on the abdominal wall.
Protect the Viscera: Immediately cover the exposed bowel with sterile towels or gauze sponges saturated with warm sterile normal saline . DO NOT attempt to push protruded organs back into the abdominal cavity, as this risks bowel perforation and peritoneal contamination.
Maintain Moisture & Heat: Apply an occlusive sterile drape over the moist dressings to prevent heat loss and tissue desiccation.
Keep NPO & Support Hemodynamics: Withhold all oral intake, initiate intravenous fluid hydration, deliver supplemental oxygen, and monitor vital signs closely for septic or hemorrhagic shock.
3. Enterocutaneous Fistulas (ECFs)
An Enterocutaneous Fistula (ECF) is an abnormal epithelialized or tract-like conduit communicating between the lumen of the gastrointestinal tract and the cutaneous surface of the skin.
Etiology & Classification Systems
Approximately 75% to 85% of ECFs occur as iatrogenic complications of abdominal surgery (e.g., anastomotic breakdown, accidental enterotomy during lysing of adhesions, or erosion from abdominal drains/mesh). The remaining cases arise spontaneously from inflammatory bowel disease (Crohn's disease), radiation enteritis, abdominal malignancies, or penetrating trauma.
ECFs are primarily classified by daily volume of fluid output:
Low-Output ECF: < 200 mL / 24 hours . Frequently originates from the distal ileum or colon. Carries a higher rate of spontaneous closure.
Moderate-Output ECF: 200 to 500 mL / 24 hours .
High-Output ECF: > 500 mL / 24 hours . Typically originates from the stomach, duodenum, or proximal jejunum. High-output fistulas drain caustic, enzyme-rich fluids, presenting high risks for severe electrolyte depletion, metabolic acidosis, hypovolemic shock, and rapid peristomal tissue breakdown.
Management Principles: The SNAP / SOW Protocol
Definitive surgical repair of an ECF is routinely delayed for 3 to 6 months after onset to allow resolution of severe intra-abdominal inflammation and dense peritoneal adhesions ("frozen abdomen"). Interim conservative management follows the SNAP protocol: S — Skin Protection & Effluent Containment (SOW: Skin-barrier / Ostomy / Wound manager)
- N — Nutrition Optimization & Fluid Balance (Restoring positive nitrogen balance)
- A — Anatomy Delineation (Fistulogram, CT imaging to identify fistula origin)
- P — Plan Definitive Surgery (Delayed 3–6 months for optimal healing)
- Peristomal Skin Protection & Effluent Management (SOW)
Fistula effluent from the proximal GI tract contains concentrated sodium, potassium, bicarbonate, and digestive enzymes (trypsin, lipase, pepsin). When this effluent contacts skin, it causes rapid enzymatic digestion of the stratum corneum, leading to severe excoriation, denudation, and intense pain.
Skin-Barrier & Pouching Systems (SOW): Apply flexible hydrocolloid skin-barrier wafers, protective barrier rings, and moldable pastes to create an airtight seal around the fistula orifice. Custom pouches or flexible ostomy appliances with drainable ports allow continuous collection and accurate volume measurement.
Negative Pressure Wound Therapy (NPWT) with Fistula Isolation: For complex, high-output fistulas situated within open abdominal wounds, NPWT can be applied with specialized silicone fistula isolation rings or specialized pouch-ing-within-a-vacuum techniques. The isolation ring shields the fistula tract while negative pressure collects effluent and promotes surrounding granulation tissue growth.
Surgical Closure & Tissue Transfer (Grafts and Flaps)
Domain 3 also assesses surgical closure or tissue transfer . Match reconstructive complexity to defect depth, perfusion, contamination, and patient goals.
Method Tissue transferred Typical indication Key exam pearl
Primary closure None (edge approximation) Clean, low-tension, well-perfused wounds Avoid if tension or dead space persists
Secondary intention None Contaminated or cavity wounds healing by granulation Needs moisture balance + bioburden control
Tertiary / delayed primary None initially Contaminated wounds closed later after cleanup Common after infection source control
Skin graft (STSG/FTSG) Epidermis ± dermis without its own blood supply Granulating beds needing epithelial cover Graft survival depends on recipient-bed perfusion; shear and hematoma kill grafts
Local / regional flap Tissue with intact vascular pedicle Exposed bone/tendon, depth needing bulk, poor graft bed Preserves blood supply; watch pedicle compression
Myocutaneous / free flap Muscle ± skin with microvascular anastomosis (free) Large composite defects, radiated beds, limb salvage Requires microsurgical expertise and intensive flap monitoring
Pre-transfer checklist for the specialist: confirm arterial inflow/venous outflow, eradicate deep infection or osteomyelitis when feasible, optimize nutrition/glucose, eliminate dead space, and plan off-loading so the reconstruction is not destroyed by the original etiology (especially plantar DFU pressure). Postoperatively, monitor flap color, capillary refill, Doppler signals, and congestion; venous obstruction is an emergency.